{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MDR", "NDM-1", "antibiotic resistance", "antimicrobial agents", "inhibitors", "\u03b2-lactam antibiotic", "\u03b2-lactamase inhibitors", "\u03b2-lactamases"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36069578", "DateCompleted": {"Year": "2022", "Month": "10", "Day": "28"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "07"}], "Language": ["eng"], "ELocationID": ["e00450-22", "10.1128/spectrum.00450-22"], "Journal": {"ISSN": "2165-0497", "JournalIssue": {"Volume": "10", "Issue": "5", "PubDate": {"Year": "2022", "Month": "Oct", "Day": "26"}}, "Title": "Microbiology spectrum", "ISOAbbreviation": "Microbiol Spectr"}, "ArticleTitle": "Broad-Spectrum Inhibitors against Class A, B, and C Type \u03b2-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.", "Pagination": {"StartPage": "e0045022", "MedlinePgn": "e0045022"}, "Abstract": {"AbstractText": ["The emergence of antibiotic resistance has led to a global crisis for the physician to handle infection control issues. All antibiotics, including colistin, have lost efficiency against emerging drug-resistant bacterial strains due to the production of metallo-\u03b2-lactamases (MBLs) and serine-\u03b2-lactamases (SBLs). Therefore, it is of the utmost importance to design inhibitors against these enzymes to block the hydrolytic action against antibiotics being used. Although various novel \u03b2-lactamase inhibitors are being authorized or are under clinical studies, the coverage of their activity spectrum does not include MDR organisms expressing multiple classes of \u03b2-lactamases at a single time. This study reports three novel broad-spectrum inhibitors effective against both SBLs and MBLs. Virtual screening, molecular docking, molecular dynamics simulations, and an <i>in silico</i> pharmacokinetic study were performed to identify the lead molecules with broad-spectrum ability to inhibit the hydrolysis of \u03b2-lactam. The selected compounds were further assessed by <i>in vitro</i> cell assays (MIC, 50% inhibitory concentration [IC<sub>50</sub>], kinetics, and fluorescence against class A, B, and C type \u03b2-lactamases) to confirm their efficacies. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was performed to check the toxicity of screened lead molecules. All three selected inhibitors were found to reduce MIC and showed good affinity against all the SBLs and MBLs produced by class A, B, and C type \u03b2-lactamases. These nontoxic novel non-\u03b2-lactam broad-spectrum inhibitors bind to the active site residues of selected \u03b2-lactamases, which are crucial for \u03b2-lactam antibiotic hydrolysis. These inhibitors may be proposed as a future drug candidate in combination with antibiotics as a single formulation to control infection caused by resistant strains. Hence, this study plays a significant role in the cure of infections caused by antibiotic-resistant bacteria. <b>IMPORTANCE</b> Several inhibitors for usage in conjunction with antibiotics have been developed. However, to date, there is no commercially available broad-spectrum \u03b2-lactamase inhibitor that targets both MBLs and SBLs. Here, we showed three novel broad-spectrum inhibitors with promising results through computational techniques and <i>in vitro</i> studies. These inhibitors are effective against both SBLs and MBLs and hence could be used as future drug candidates to treat infections caused by multidrug-resistant bacteria producing both types of enzymes (SBLs and MBLs)."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Microbiology and Molecular Biology Lab, Interdisciplinary Biotechnology Unit, Aligarh Muslim Universitygrid.411340.3, Aligarh, Uttar Pradesh, India."}], "LastName": "Farhat", "ForeName": "Nabeela", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Microbiology and Molecular Biology Lab, Interdisciplinary Biotechnology Unit, Aligarh Muslim Universitygrid.411340.3, Aligarh, Uttar Pradesh, India."}, {"Identifier": [], "Affiliation": "Department of Life Sciences, Uttarakhand Technical University, Dehradun, Uttarakhand, India."}], "LastName": "Gupta", "ForeName": "Divya", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Microbiology and Molecular Biology Lab, Interdisciplinary Biotechnology Unit, Aligarh Muslim Universitygrid.411340.3, Aligarh, Uttar Pradesh, India."}], "LastName": "Ali", "ForeName": "Abid", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal & Aromatic Plants, CIMAP, Lucknow, Uttar Pradesh, India."}], "LastName": "Kumar", "ForeName": "Yogesh", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Microbiology and Molecular Biology Lab, Interdisciplinary Biotechnology Unit, Aligarh Muslim Universitygrid.411340.3, Aligarh, Uttar Pradesh, India."}], "LastName": "Akhtar", "ForeName": "Farheen", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology, New Delhi, Delhi, India."}], "LastName": "Kulanthaivel", "ForeName": "Senthilguru", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology, New Delhi, Delhi, India."}], "LastName": "Mishra", "ForeName": "Prashant", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CSIR-Central Institute of Medicinal & Aromatic Plants, CIMAP, Lucknow, Uttar Pradesh, India."}], "LastName": "Khan", "ForeName": "Feroz", "Initials": "F"}, {"Identifier": ["0000-0001-9191-9423"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Microbiology and Molecular Biology Lab, Interdisciplinary Biotechnology Unit, Aligarh Muslim Universitygrid.411340.3, Aligarh, Uttar Pradesh, India."}], "LastName": "Khan", "ForeName": "Asad U", "Initials": "AU"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Microbiol Spectr", "NlmUniqueID": "101634614", "ISSNLinking": "2165-0497"}, "ChemicalList": [{"RegistryNumber": "EC 3.5.2.6", "NameOfSubstance": "beta-Lactamases"}, {"RegistryNumber": "0", "NameOfSubstance": "beta-Lactamase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "Z67X93HJG1", "NameOfSubstance": "Colistin"}, {"RegistryNumber": "0", "NameOfSubstance": "beta-Lactams"}, {"RegistryNumber": "452VLY9402", "NameOfSubstance": "Serine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "beta-Lactamases"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "beta-Lactamase Inhibitors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": [], "DescriptorName": "Hydrolysis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Colistin"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "beta-Lactams"}, {"QualifierName": ["metabolism"], "DescriptorName": "Bacteria"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Serine"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Drawz SM, Bonomo RA. 2010. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev 23:160\u2013201. doi:10.1128/CMR.00037-09.", "ArticleIdList": ["10.1128/CMR.00037-09", "PMC2806661", "20065329"]}, {"Citation": "Bush K, Jacoby GA. 2010. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother 54:969\u2013976. doi:10.1128/AAC.01009-09.", "ArticleIdList": ["10.1128/AAC.01009-09", "PMC2825993", "19995920"]}, {"Citation": "Karras G, Giannakaki V, Kotsis V, Miyakis S. 2012. Novel antimicrobial agents against multi-drug-resistant gram-negative bacteria: an overview. Recent Pat Antiinfect Drug Discov 7:175\u2013181. doi:10.2174/157489112803521922.", "ArticleIdList": ["10.2174/157489112803521922", "23061790"]}, {"Citation": "Ali A, Gupta D, Khan AU. 2019. Role of non-active site residues in maintaining New Delhi metallo-\u03b2-lactamase-1(NDM-1) function: an approach of site directed mutagenesis and docking. FEMS Microbiol Lett 368:fnz003. doi:10.1093/femsle/fnz003.", "ArticleIdList": ["10.1093/femsle/fnz003", "30624634"]}, {"Citation": "Skagseth S, Akhter S, Paulsen MH, Muhammad Z, Lauksund S, Samuelsen \u00d8, Leiros HKS, Bayer A. 2017. Metallo-\u03b2-lactamase inhibitors by bioisosteric replacement: preparation, activity and binding. Eur J Med Chem 135:159\u2013173. doi:10.1016/j.ejmech.2017.04.035.", "ArticleIdList": ["10.1016/j.ejmech.2017.04.035", "28445786"]}, {"Citation": "Stachyra T, P\u00e9chereau MC, Bruneau JM, Claudon M, Fr\u00e8re JM, Miossec C, Coleman K, Black MT. 2010. Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor. Antimicrob Agents Chemother 54:5132\u20135138. doi:10.1128/AAC.00568-10.", "ArticleIdList": ["10.1128/AAC.00568-10", "PMC2981269", "20921316"]}, {"Citation": "Livermore DM. 1995. \u03b2-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8:557\u2013584. doi:10.1128/CMR.8.4.557.", "ArticleIdList": ["10.1128/CMR.8.4.557", "PMC172876", "8665470"]}, {"Citation": "Gazouli M, Legakis NJ, Tzouvelekis LS. 1998. Effect of substitution of Asn for Arg-276 in the cefotaxime-hydrolyzing class A\u03b2-lactamase CTX-M-4. FEMS Microbiol Lett 169:289\u2013293. doi:10.1111/j.1574-6968.1998.tb13331.x.", "ArticleIdList": ["10.1111/j.1574-6968.1998.tb13331.x", "9868772"]}, {"Citation": "Zhang H, Hao Q. 2011. Crystal structure of NDM-1 reveals a common \u03b2-lactam hydrolysis mechanism. FASEB J 25:2574\u20132582. doi:10.1096/fj.11-184036.", "ArticleIdList": ["10.1096/fj.11-184036", "21507902"]}, {"Citation": "Kim Y, Tesar C, Mire J, Jedrzejczak R, Binkowski A, Babnigg G, Sacchettini J, Joachimiak A. 2011. Structure of apo- and monometalated forms of NDM-1: a highly potent carbapenem-hydrolyzing metallo-\u03b2-lactamase. PLoS One 6:e24621. doi:10.1371/journal.pone.0024621.", "ArticleIdList": ["10.1371/journal.pone.0024621", "PMC3169612", "21931780"]}, {"Citation": "Ekins S, Rose J. 2002. In silico ADME/Tox: the state of the art. J Mol Graph Model 20:305\u2013309. doi:10.1016/S1093-3263(01)00127-9.", "ArticleIdList": ["10.1016/S1093-3263(01)00127-9", "11858639"]}, {"Citation": "Eftink MR, Ghiron CA. 1981. Fluorescence quenching studies with proteins. Anal Biochem 114:199\u2013227. doi:10.1016/0003-2697(81)90474-7.", "ArticleIdList": ["10.1016/0003-2697(81)90474-7", "7030122"]}, {"Citation": "Eftink MR, Ghiron CA. 1976. Exposure of tryptophanyl residues in proteins. Quantitative determination by fluorescence quenching studies. Biochemistry 15:672\u2013680. doi:10.1021/bi00648a035.", "ArticleIdList": ["10.1021/bi00648a035", "1252418"]}, {"Citation": "Lakowicz JR. 1988. Principles of frequency-domain fluorescence spectroscopy and applications to cell membranes. Subcell Biochem 13:89\u2013126. doi:10.1007/978-1-4613-9359-7_3.", "ArticleIdList": ["10.1007/978-1-4613-9359-7_3", "2577864"]}, {"Citation": "Shahabadi N, Khorshidi A, Moghadam NH. 2013. Study on the interaction of the epilepsy drug, zonisamide with human serum albumin (HSA) by spectroscopic and molecular docking techniques. Spectrochim Acta A Mol Biomol Spectrosc 114:627\u2013632. doi:10.1016/j.saa.2013.05.092.", "ArticleIdList": ["10.1016/j.saa.2013.05.092", "23811149"]}, {"Citation": "Chen Z, Xu H, Zhu Y, Liu J, Wang K, Wang P, Shang S, Yi X, Wang Z, Shao W, Zhang S. 2014. Understanding the fate of an anesthetic, nalorphine upon interaction with human serum albumin: a photophysical and mass-spectroscopy approach. RSC Advances 4:25410\u201325419. doi:10.1039/C4RA03541K.", "ArticleIdList": ["10.1039/C4RA03541K"]}, {"Citation": "Kuzin AP, Nukaga M, Nukaga Y, Hujer AM, Bonomo RA, Knox JR. 1999. Structure of the SHV-1 \u03b2-lactamase. Biochemistry 38:5720\u20135727. doi:10.1021/bi990136d.", "ArticleIdList": ["10.1021/bi990136d", "10231522"]}, {"Citation": "Lahiri SD, Mangani S, Durand-Reville T, Benvenuti M, De Luca F, Sanyal G, Docquier JD. 2013. Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and pseudomonas aeruginosa AmpC \u03b2-lactamases. Antimicrob Agents Chemother 57:2496\u20132505. doi:10.1128/AAC.02247-12.", "ArticleIdList": ["10.1128/AAC.02247-12", "PMC3716117", "23439634"]}, {"Citation": "Fonz\u00e9 E, Charlier P, To\u2019th Y, Vermeire M, Raquet X, Dubus A, Fr\u00e8re JM. 1995. TEM1 beta-lactamase structure solved by molecular replacement and refined structure of the S235A mutant. Acta Crystallogr D Biol Crystallogr 51:682\u2013694. doi:10.1107/S0907444994014496.", "ArticleIdList": ["10.1107/S0907444994014496", "15299797"]}, {"Citation": "Petrella S, Ziental-Gelus N, Mayer C, Renard M, Jarlier V, Sougakoff W. 2008. Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A \u03b2-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France. Antimicrob Agents Chemother 52:3725\u20133736. doi:10.1128/AAC.00163-08.", "ArticleIdList": ["10.1128/AAC.00163-08", "PMC2565876", "18625772"]}, {"Citation": "Zhang H, Ma G, Zhu Y, Zeng L, Ahmad A, Wang C, Pang B, Fang H, Zhao L, Hao Q. 2018. Active-site conformational fluctuations promote the enzymatic activity of NDM-1. Antimicrob Agents Chemother 62:e01579-18. doi:10.1128/AAC.01579-18.", "ArticleIdList": ["10.1128/AAC.01579-18", "PMC6201099", "30150473"]}, {"Citation": "McKinney DC, Zhou F, Eyermann CJ, Ferguson AD, Prince DB, Breen J, Giacobbe RA, Lahiri S, Verheijen JC. 2015. 4,5-Disubstituted 6-aryloxy-1,3-dihydrobenzo[c][1,2]oxaboroles are broad-spectrum serine \u03b2-lactamase inhibitors. ACS Infect Dis 1:310\u2013316. doi:10.1021/acsinfecdis.5b00031.", "ArticleIdList": ["10.1021/acsinfecdis.5b00031", "27622821"]}, {"Citation": "Biovia. 2015. Dassault Systemes Biovia, Discovery Studio modelling environment, release 4.5. Accelrys Software, Inc. 98\u2013104."}, {"Citation": "DeLano WL. 2002. PyMOL: an open-source molecular graphics tool. CCP4 Newsl Protein Crystallography 40:82\u201392."}, {"Citation": "Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE. 2019. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res 47:D1102\u2013D1109. doi:10.1093/nar/gky1033.", "ArticleIdList": ["10.1093/nar/gky1033", "PMC6324075", "30371825"]}, {"Citation": "Jones G, Willett P, Glen RC. 1995. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J Mol Biol 245:43\u201353. doi:10.1016/S0022-2836(95)80037-9.", "ArticleIdList": ["10.1016/S0022-2836(95)80037-9", "7823319"]}, {"Citation": "Oleg T, Oslon AJ. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. doi:10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Singh A, Somvanshi P, Grover A. 2019. Drug repurposing against arabinosyl transferase (EmbC) of Mycobacterium tuberculosis: essential dynamics and free energy minima based binding mechanics analysis. Gene 693:114\u2013126. doi:10.1016/j.gene.2019.01.029.", "ArticleIdList": ["10.1016/j.gene.2019.01.029", "30716439"]}, {"Citation": "Singh A, Somvanshi P, Grover A. 2019. Pyrazinamide drug resistance in RpsA mutant (\u0394438A) of Mycobacterium tuberculosis: dynamics of essential motions and free-energy landscape analysis. J Cell Biochem 120:7386\u20137402. doi:10.1002/jcb.28013.", "ArticleIdList": ["10.1002/jcb.28013", "30390330"]}, {"Citation": "Singh A, Grover S, Sinha S, Das M, Somvanshi P, Grover A. 2017. Mechanistic principles behind molecular mechanism of rifampicin resistance in mutant RNA polymerase beta subunit of Mycobacterium tuberculosis. J Cell Biochem 118:4594\u20134606. doi:10.1002/jcb.26124.", "ArticleIdList": ["10.1002/jcb.26124", "28485504"]}, {"Citation": "Van Gunsteren WF, Billeter SR, Eising AA, H\u00fcnenberger PH, Kr\u00fcger PKHC, Mark AE, Scott WRP, Tironi IG. 1996. Biomolecular simulation: the GROMOS96 manual and user guide. Vdf Hochschulverlag AG an der ETH Z\u00fcrich, Zurich, Switzerland."}, {"Citation": "Sch\u00fcttelkopf AW, Van Aalten DM. 2004. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 60:1355\u20131363. doi:10.1107/S0907444904011679.", "ArticleIdList": ["10.1107/S0907444904011679", "15272157"]}, {"Citation": "Sinha S, Tyagi C, Goyal S, Jamal S, Somvanshi P, Grover A. 2016. Fragment based G-QSAR and molecular dynamics based mechanistic simulations into hydroxamic-based HDAC inhibitors against spinocerebellar ataxia. J Biomol Struct Dyn 34:2281\u20132295. doi:10.1080/07391102.2015.1113386.", "ArticleIdList": ["10.1080/07391102.2015.1113386", "26510381"]}, {"Citation": "Sinha S, Verma S, Singh A, Somvanshi P, Grover A. 2018. Simulation based investigation of deleterious nsSNPs in ATXN2 gene and its structural consequence toward spinocerebellar ataxia. J Cell Biochem 119:499\u2013510. doi:10.1002/jcb.26209.", "ArticleIdList": ["10.1002/jcb.26209", "28612427"]}, {"Citation": "Khan AU, Ali A, Srivastava G, Sharma A. 2017. Potential inhibitors designed against NDM-1 type metallo-\u03b2-lactamases: an attempt to enhance efficacies of antibiotics against multi-drug-resistant bacteria. Sci Rep 7:9207. doi:10.1038/s41598-017-09588-1.", "ArticleIdList": ["10.1038/s41598-017-09588-1", "PMC5569068", "28835636"]}, {"Citation": "Ali A, Maryam L, Srivastava G, Sharma A, Khan AU. 2018. Designing of inhibitors against CTX-M-15 type \u03b2-lactamase: potential drug candidate against \u03b2-lactamases-producing multi-drug-resistant bacteria. J Biomol Struct Dyn 36:1806\u20131821. doi:10.1080/07391102.2017.1335434.", "ArticleIdList": ["10.1080/07391102.2017.1335434", "28545327"]}, {"Citation": "Clinical and Laboratory Standards Institute. 2014. 24th informational supplement (January). M100-S24. CLSI, Wayne, PA."}, {"Citation": "Andrews JM. 2001. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48:5\u201316. doi:10.1093/jac/48.suppl_1.5.", "ArticleIdList": ["10.1093/jac/48.suppl_1.5", "11420333"]}, {"Citation": "Cheng Y, Prusoff WH. 1973. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099\u20133108. doi:10.1016/0006-2952(73)90196-2.", "ArticleIdList": ["10.1016/0006-2952(73)90196-2", "4202581"]}, {"Citation": "De Meester F, Joris B, Reckinger G, Bellefroid-Bourguignon C, Fr\u00e8re J, Waley SG. 1987. Automated analysis of enzyme inactivation phenomena: application to \u03b2-lactamases and DD-peptidases. Biochemistry Pharmacol 36:2393\u20132403. doi:10.1016/0006-2952(87)90609-5.", "ArticleIdList": ["10.1016/0006-2952(87)90609-5", "3038122"]}, {"Citation": "Segel IH. 1976. Biochemical calculations, 2nd ed, p 236\u2013241. John Wiley & Sons, New York, NY."}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "7", "Hour": "9", "Minute": "4"}, {"Year": "2022", "Month": "9", "Day": "7"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36069578", "PMC9603770", "10.1128/spectrum.00450-22"]}}], "PubmedBookArticle": []}